145 related articles for article (PubMed ID: 25766921)
1. Rod shaped nanocrystals exhibit superior in vitro dissolution and in vivo bioavailability over spherical like nanocrystals: a case study of lovastatin.
Guo M; Fu Q; Wu C; Guo Z; Li M; Sun J; He Z; Yang L
Colloids Surf B Biointerfaces; 2015 Apr; 128():410-418. PubMed ID: 25766921
[TBL] [Abstract][Full Text] [Related]
2. Development of novel mesoporous nanomatrix-supported lipid bilayers for oral sustained delivery of the water-insoluble drug, lovastatin.
Zhang Y; Zhang H; Che E; Zhang L; Han J; Yang Y; Wang S; Zhang M; Gao C
Colloids Surf B Biointerfaces; 2015 Apr; 128():77-85. PubMed ID: 25731096
[TBL] [Abstract][Full Text] [Related]
3. Novel extended-release formulation of lovastatin by one-step melt granulation: in vitro and in vivo evaluation.
Ochoa L; Igartua M; Hernández RM; Gascón AR; Solinis MA; Pedraz JL
Eur J Pharm Biopharm; 2011 Feb; 77(2):306-12. PubMed ID: 21172434
[TBL] [Abstract][Full Text] [Related]
4. Fabrication of fenofibrate nanocrystals by probe sonication method for enhancement of dissolution rate and oral bioavailability.
Ige PP; Baria RK; Gattani SG
Colloids Surf B Biointerfaces; 2013 Aug; 108():366-73. PubMed ID: 23602990
[TBL] [Abstract][Full Text] [Related]
5. Preparation and Evaluation of Diosgenin Nanocrystals to Improve Oral Bioavailability.
Liu CZ; Chang JH; Zhang L; Xue HF; Liu XG; Liu P; Fu Q
AAPS PharmSciTech; 2017 Aug; 18(6):2067-2076. PubMed ID: 27995466
[TBL] [Abstract][Full Text] [Related]
6. Development of surface stabilized candesartan cilexetil nanocrystals with enhanced dissolution rate, permeation rate across CaCo-2, and oral bioavailability.
Jain S; Reddy VA; Arora S; Patel K
Drug Deliv Transl Res; 2016 Oct; 6(5):498-510. PubMed ID: 27129488
[TBL] [Abstract][Full Text] [Related]
7. Preparation, characterization, and in vitro and in vivo evaluation of lovastatin solid lipid nanoparticles.
Suresh G; Manjunath K; Venkateswarlu V; Satyanarayana V
AAPS PharmSciTech; 2007 Mar; 8(1):24. PubMed ID: 17408223
[TBL] [Abstract][Full Text] [Related]
8. In Vitro and In Vivo Evaluation of Olmesartan Medoxomil Microcrysta ls and Nanocrystals: Preparation, Characterization, and Pharmacokinet ic Comparison in Beagle Dogs.
Chai R; Gao H; Ma Z; Guo M; Fu Q; Liu H; He Z
Curr Drug Deliv; 2019; 16(6):500-510. PubMed ID: 31244438
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticles of Lovastatin: Design, Optimization and in vivo Evaluation.
Gaber DA
Int J Nanomedicine; 2020; 15():4225-4236. PubMed ID: 32606674
[TBL] [Abstract][Full Text] [Related]
10. Preparation of apigenin nanocrystals using supercritical antisolvent process for dissolution and bioavailability enhancement.
Zhang J; Huang Y; Liu D; Gao Y; Qian S
Eur J Pharm Sci; 2013 Mar; 48(4-5):740-7. PubMed ID: 23305994
[TBL] [Abstract][Full Text] [Related]
11. Redispersible, dry emulsion of lovastatin protects against intestinal metabolism and improves bioavailability.
Ge Z; Zhang XX; Gan L; Gan Y
Acta Pharmacol Sin; 2008 Aug; 29(8):990-7. PubMed ID: 18664332
[TBL] [Abstract][Full Text] [Related]
12. Enhanced dissolution rate and oral bioavailability of simvastatin nanocrystal prepared by sonoprecipitation.
Jiang T; Han N; Zhao B; Xie Y; Wang S
Drug Dev Ind Pharm; 2012 Oct; 38(10):1230-9. PubMed ID: 22229827
[TBL] [Abstract][Full Text] [Related]
13. Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics.
Chen CC; Tsai TH; Huang ZR; Fang JY
Eur J Pharm Biopharm; 2010 Mar; 74(3):474-82. PubMed ID: 20060469
[TBL] [Abstract][Full Text] [Related]
14. Nimodipine nanocrystals for oral bioavailability improvement: preparation, characterization and pharmacokinetic studies.
Fu Q; Sun J; Zhang D; Li M; Wang Y; Ling G; Liu X; Sun Y; Sui X; Luo C; Sun L; Han X; Lian H; Zhu M; Wang S; He Z
Colloids Surf B Biointerfaces; 2013 Sep; 109():161-6. PubMed ID: 23668980
[TBL] [Abstract][Full Text] [Related]
15. Design, optimization and in vitro-in vivo evaluation of smart nanocaged carrier delivery of multifunctional PEG-chitosan stabilized silybin nanocrystals.
Liu Y; Wang Y; Zhao J
Int J Biol Macromol; 2019 Mar; 124():667-680. PubMed ID: 30502425
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous determination of lovastatin and its metabolite lovastatin acid in rat plasma using UPLC-MS/MS with positive/negative ion-switching electrospray ionization: Application to a pharmacokinetic study of lovastatin nanosuspension.
Guo M; Zhao L; Li M; Fu Q; Pu X; Liu B; He Z; Yang L
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jun; 1023-1024():55-61. PubMed ID: 27200472
[TBL] [Abstract][Full Text] [Related]
17. Enhanced oral bioavailability of glycyrrhetinic acid via nanocrystal formulation.
Lei Y; Kong Y; Sui H; Feng J; Zhu R; Wang W
Drug Deliv Transl Res; 2016 Oct; 6(5):519-25. PubMed ID: 27206446
[TBL] [Abstract][Full Text] [Related]
18. Hyperoside nanocrystals for HBV treatment: process optimization, in vitro and in vivo evaluation.
Shen B; Wu N; Shen C; Zhang F; Wu Y; Xu P; Zhang L; Wu W; Lu Y; Han J; Wang Y; Yuan H
Drug Dev Ind Pharm; 2016 Nov; 42(11):1772-81. PubMed ID: 27032257
[TBL] [Abstract][Full Text] [Related]
19. Effect of particle size on solubility, dissolution rate, and oral bioavailability: evaluation using coenzyme Q₁₀ as naked nanocrystals.
Sun J; Wang F; Sui Y; She Z; Zhai W; Wang C; Deng Y
Int J Nanomedicine; 2012; 7():5733-44. PubMed ID: 23166438
[TBL] [Abstract][Full Text] [Related]
20. Preparation and pharmacodynamic assessment of ezetimibe nanocrystals: Effect of P-gp inhibitory stabilizer on particle size and oral absorption.
Srivalli KMR; Mishra B
Colloids Surf B Biointerfaces; 2015 Nov; 135():756-764. PubMed ID: 26342321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
